Salbutamol Completed Phase 1 / 2 Trials for Pompe's Disease Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01859624Albuterol in Individuals With Late Onset Pompe Disease (LOPD)